Contineum Therapeutics, Inc. · NASDAQ:CTNM

Contineum Therapeutics, Inc. insider trades

Contineum Therapeutics, Inc.'s insiders made 0 buys and 14 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

InsiderTradeSharesPriceValueDate
Stengone Carmine N.
Director, Officer: CEO and President
Sale2,500USD 16.46US$41,150Sep 8, 2026
Stengone Carmine N.
Director, Officer: CEO and President
Sale2,500USD 16.01US$40,025Aug 3, 2026
Lorrain Daniel S.
Officer: Chief Scientific Officer
Sale25USD 16.00US$400Jul 9, 2026
Lorrain Daniel S.
Officer: Chief Scientific Officer
Sale1,015USD 16.00US$16,240Jul 8, 2026
Stengone Carmine N.
Director, Officer: CEO and President
Sale2,500USD 16.00US$40,000Jul 8, 2026
Lorrain Daniel S.
Officer: Chief Scientific Officer
Sale5,852USD 15.67US$91,701Jul 1, 2026
Lorrain Daniel S.
Officer: Chief Scientific Officer
Sale2,501USD 16.24US$40,616Jul 1, 2026
Lorrain Daniel S.
Officer: Chief Scientific Officer
Sale28,826USD 16.04US$462KJun 30, 2026
Stengone Carmine N.
Director, Officer: CEO and President
Sale10,000USD 16.01US$160KJun 30, 2026
Watkins Tim
Officer: CMO & Head of Development
Sale10,833USD 16.02US$174KJun 30, 2026
Lorrain Daniel S.
Officer: Chief Scientific Officer
Sale4,170USD 13.16US$54,877Jun 1, 2026
Lorrain Daniel S.
Officer: Chief Scientific Officer
Sale3,870USD 13.06US$50,542May 1, 2026
Lorrain Daniel S.
Officer: Chief Scientific Officer
Sale300USD 13.84US$4,152May 1, 2026
Lorrain Daniel S.
Officer: Chief Scientific Officer
Sale4,170USD 13.43US$56,003Apr 6, 2026

Contineum Therapeutics, Inc. shareholders